Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethics in Research01:56

Ethics in Research

23.8K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.8K
Translation01:31

Translation

143.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
143.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unresponsive Systemic Mastocytosis in a Young AML With RUNX1::RUNX1T1 Fusion With Rare KIT c.1255_1257delGAC Mutation: A Clinical Deadlock.

Journal of pediatric hematology/oncology·2026
Same author

Decoding the Haematological Enigma: Insights from Primary Hypertrophic Osteoarthropathy Case Studies.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Role of Flow Cytometric Enumeration of Circulating hMICL (CD371) Positive Leukemic Stem Cells in Diagnosis and Prognostication of BCR::ABL1-Negative Myeloproliferative Neoplasms.

International journal of laboratory hematology·2026
Same author

Sitosterolemia: Unveiling an Underdiagnosed Case Series of Haemolytic Anaemia.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Hypoxia-induced metabolic and apoptotic reprogramming enhances immunomodulation in Wharton's jelly mesenchymal stem cells.

iScience·2026
Same author

Comprehensive transcriptomic analysis highlights immune and cell-cycle dysregulation in Diamond-Blackfan Anaemia.

Molecular genetics and genomics : MGG·2026
Same journal

Compound Heterozygous Hemoglobin Minneapolis-Laos and Codon 41/42 (-TTCT) in a Thai Female Adult: A Case Report and Literature Review.

Hemoglobin·2026
Same journal

Hb F-SickKids (<i>HBG2</i>: C.308A > G): A Novel γ-Globin Variant Associated with Transient Neonatal Cyanosis.

Hemoglobin·2026
Same journal

Pyruvate Kinase Activation in the Management of Thalassemia and Sickle Cell Disease.

Hemoglobin·2026
Same journal

Genotypic Characterization of Hemoglobinopathies in Azerbaijan: A Review of 10 Years at a Referral Center.

Hemoglobin·2026
Same journal

Successful Management of Transfusion-Dependent Unstable Hemoglobin Perth with Splenectomy: First Report from Iran and Literature Review.

Hemoglobin·2026
Same journal

Unstable Hemoglobin Variants: Molecular Mechanisms, Clinical Phenotypes, and a Practical Diagnostic and Management Approach.

Hemoglobin·2026
See all related articles

Related Experiment Video

Updated: Sep 1, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K

Thalassemia in India.

Roshan B Colah1, Tulika Seth2

  • 1Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, King Edward Memorial Hospital, Mumbai, Maharashtra, India.

Hemoglobin
|August 11, 2022
PubMed
Summary
This summary is machine-generated.

Hemoglobinopathies pose a significant challenge in India, particularly in rural areas with limited healthcare spending. A proposed national policy aims to improve management and prevention through comprehensive care, genetic counseling, and a national registry.

Keywords:
Epidemiology and preventionIndiahealth economicsmanagementthalassemia

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.3K

Related Experiment Videos

Last Updated: Sep 1, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

8.3K

Area of Science:

  • Genetics
  • Public Health
  • Hematology

Background:

  • Hemoglobinopathies, including beta-thalassemia, are prevalent in India, with significant rural impact and low healthcare expenditure.
  • Over 80 beta-thalassemia mutations exist in Indians, with delta gene mutations complicating carrier diagnosis.
  • Limited access to prenatal diagnosis (PND) and hematopoietic stem cell transplants (HSCTs) exacerbates the challenge.

Purpose of the Study:

  • To highlight the challenges in managing hemoglobinopathies in India.
  • To discuss the economic burden and disparities in care.
  • To introduce a proposed national policy for comprehensive management and prevention.

Main Methods:

  • Review of existing data on hemoglobinopathy prevalence and healthcare costs in India.
  • Analysis of current diagnostic and treatment capacities, including PND and HSCT.
  • Outline of the proposed National Policy framework.

Main Results:

  • High prevalence of beta-thalassemias (7500-12000 new births annually) and other hemoglobin variants.
  • Significant projected increase in annual care costs for beta-thalassemia patients.
  • Limited availability of HSCT (approx. 250 annually) and disparities in care quality.

Conclusions:

  • A comprehensive National Policy is crucial for effective management and prevention of hemoglobinopathies in India.
  • The policy should focus on improving access to care, genetic counseling, PND, and establishing a National Registry.
  • Addressing healthcare disparities and augmenting public health services are key to mitigating the impact of these genetic disorders.